Glynis Ablon, MD

Ablon Skin Institute and Research Center
Manhattan Beach, CA
USA 90266
Papers:
A Randomized, Dose-Escalating, Double-Blind Study to Evaluate Abobotulinumtoxina for the Treatment of Moderate-to-Severe Glabellar Lines